This ticker has not been starred yet LSTA Lisata Therapeutics, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.97
Leverage 21.32%
Market Cap $ 17.7m
PE 0.00
Dividend Yield 0.00%
Profit $ -18.2m
Margin -1982.32%

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing cellular therapies to reverse disease and/or promote regeneration of damaged tissue. The company is headquartered in Basking Ridge, New Jersey.

Subscribe Now For Access - Only $1.99 Per Month